Altamira Therapeutics Ltd. (CYTO) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Altamira Therapeutics Ltd. has announced its Annual General Meeting for shareholders to be held on May 16, 2024, in Bermuda, with key agenda items including the election of four director nominees, appointment of auditors, and approval of executive compensation. Additionally, proposals will be voted on concerning the reduction of the share premium account, increasing authorised share capital, and other business matters. The company has made all relevant documentation available for shareholder review on its website and offers electronic voting options.
For further insights into CYTO stock, check out TipRanks’ Stock Analysis page.